MedPageToday
MedPage Today) — DENVER — In women with type 2 diabetes, use of GLP-1 receptor agonists was associated with a reduced risk of new-onset uterine fibroids compared with other antidiabetic agents, a retrospective cohort study suggested.
Among…
Read More
GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids
Joan Latson
16:19
MedPage Today) — DENVER — In women with type 2 diabetes, use of GLP-1 receptor agonists was associated with a reduced risk of new-onset uterine fibroids compared with other antidiabetic agents, a retrospective cohort study suggested. Among…
